Roche Holding AG

Roche Holding AG is a Swiss multinational healthcare holding company recognized globally as a leading pharmaceutical and diagnostics innovator. Founded in 1896, Roche has established itself as one of the world’s largest pharmaceutical companies, particularly noted for its pioneering work in oncology, where it is the top provider of cancer treatments worldwide. The company operates through two main divisions: pharmaceuticals and diagnostics, providing a broad portfolio that addresses a wide range of therapeutic areas such as oncology, cardiometabolic diseases, infectious diseases, neuroscience, and women’s health. Roche is also a major producer of in-vitro diagnostics, playing a vital role in advancing personalized healthcare and improving patient outcomes. With its ongoing commitment to research and development, Roche is among the largest investors in pharmaceutical R&D globally. Its contributions extend beyond commercial products, encompassing a strong social responsibility focus, involvement in global health initiatives, and adherence to sustainable business practices. This comprehensive approach positions Roche Holding AG as a critical player in shaping the future landscape of healthcare and biotechnology.